Gene Therapy Treatments for Sickle Cell Disease | Humana

Gene Therapy Treatments for Sickle Cell Disease

Humana · PayerPolicy · HUMANA-GENE-THERAPY-TREATMENTS-FOR-SICKLE-CELL-DISEASE-MA

Status: Active
Effective: February 2, 2026
Last reviewed by Humana: January 13, 2026
Last checked by Backwork: September 30, 2026

Summary of the payer’s published policy. Not a coverage determination — confirm with Humana before submitting.

Get free alerts when Humana changes this policy

Free account. Policy pages stay open to everyone.

Codes in this policy

Each code’s status is what the policy records for it. This page does not show the policy’s criteria. Read them in the payer’s source.

Codes this policy lists and each code’s status in the policy
Code	Code system	Status in this policy
C9399	HCPCS	Covered
J3392	HCPCS	Covered
J3394	HCPCS	Covered
J3490	HCPCS	Covered
J3590	HCPCS	Covered
XW133H9	ICD10PCS	Covered
XW133J8	ICD10PCS	Covered
XW143H9	ICD10PCS	Covered
XW143J8	ICD10PCS	Covered